Page last updated: 2024-12-11

22,23-dihydroergosterol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

22,23-dihydroergosterol: RN given refers to (3beta)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

ergosta-5,7-dien-3beta-ol : A phytosterol consiting of ergostane having double bonds at the 5,6- and 7,8-positions as well as a 3beta-hydroxy group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5326970
CHEBI ID66918
SCHEMBL ID5133206
MeSH IDM0059228

Synonyms (32)

Synonym
24-methylcholesta-5,7-dien-3-.beta.-ol
(3s,9s,10r,13r,14r,17r)-17-[(2r,5s)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-3-ol
516-79-0
ergosta-5,7-dien-3beta-ol
LMST01031027
22-dihydroergosterol
22,23-dihydroergosterol, non-irradiated
azw48ayg7c ,
unii-azw48ayg7c
22,23-dihydroergosterol
einecs 208-226-3
(3beta)-ergosta-5,7-dien-3-ol
delta(5,7)-ergostadien-3beta-ol
ergosta-5,7-dien-3betabeta-ol
24-methylcholesta-5,7-dien-3-beta-ol
delta(5,7)-ergostadienol
24s-methylcholesta-5,7-dien-3beta-ol
5,7-ergostadienol
provitamin d4
CHEBI:66918
dihydroergosterol
SCHEMBL5133206
24s-methylcholesta-5,7-dien-3.beta.-ol
.delta.5,7-ergostadienol
ergosta-5,7-dien-3.beta.-ol
5,7-ergostadien-3.beta.-ol
ergosta-5,7-dien-3-ol, (3.beta.)-
.delta.5,7-ergostadien-3.beta.-ol
ergosta-5,7-dien-3-ol #
Q27135518
(3s,9s,10r,13r,14r,17r)-17-((2r,5s)-5,6-dimethylheptan-2-yl)-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1h-cyclopenta(a)phenanthren-3-ol
(3.beta.)-ergosta-5,7-dien-3-ol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
3beta-sterolA sterol in which the hydroxy group at position 3 has beta- configuration.
ergostanoid
phytosterolsSterols similar to cholesterol which occur in plants and vary only in carbon side chains and/or presence or absence of a double bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
ergosterol biosynthesis II113
superpathway of ergosterol biosynthesis II133
superpathway of ergosterol biosynthesis II135
ergosterol biosynthesis II116

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (50.00)18.7374
1990's1 (10.00)18.2507
2000's1 (10.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.26

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.26 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.83 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.26)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]